A venture capital arm of a family office actively invests in early stage startups. Of their investments, about a third are in healthcare. The firm is a fairly opportunistic investor, and will consider therapeutics, medical device, diagnostics and digital health companies, but will only invest in companies that have a strong IP position and a strong management team. The firm generally invests in seed-series A rounds , investing $500k-3M in rounds generally in the range of $2 to $15 million. The firm prefers to invest in therapeutics companies that are IND-ready, and in device and diagnostics companies that have some clinical data. The firm will invest globally, but prefers to invest in companies based in the US.
The firm invests opportunistically in therapeutics, medical devices, diagnostics and, to a lesser degree, digital health technologies. The firm generally does not invest in consumer-facing/telehealth-related digital health companies. Historically, the firm has invested in AI-based digital health technologies, and will not invest in a digital technology that does not have strong IP. The firm is generally agnostic to indication.
The firm looks for companies with strong IP and management teams. The firm is willing to lead or co-invest, but will generally not participate in rounds larger than $30M. When acting as a lead investor, the firm is a very active investor, and plays a large role in helping company development.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Bill Kuziel, an Investor at MedPro Investors, shared that he had many meetings on the first day, and all of them went off without a hitch.
Aaron Sandoski, Co-Founder and Managing Director of Norwich Ventures, even shared, “Actually, I preferred it to in-person meetings since the flexibility of the multi-day approach made it much easier to fit conversations into my schedule.”
Haifeng Cui, Senior Director, Scientific Innovation at Johnson & Johnson Innovation said “I really enjoyed the digital RESI meetings, very easy to use and convenient. Given the experience I had, I am highly interested to participate for the next two events.”
Jim Burden, President of Dorset Capital, made a note of mentioning that they would be following up with companies they ‘met’ at Digital RESI. As Jim said, “We intend to pursue at least three companies we both found interesting and worthwhile through the event. You stepped up to the challenge of one of the first video conferences and it was a success.”
